Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
I talked to a patient not one of ours
Imunotherapy in combination with chemotherapy is emerging as a new standard of care in this setting, and the approval of Imfinzi offers an important new option for patients with mismatch repair deficient disease, Dave Fredrickson, executive vice president of the oncology business unit at AstraZeneca, said in a press release
Potential Benefits Beyond Glucose Control Studies suggest that GLP-1RAs may offer additional health benefits beyond blood sugar regulation
Strength work two to three times weekly helps maintain metabolic rate and functional capacity
US$ 22.59
US$ 28.42
US$ 26.47
US$ 28.56
US$ 29.74
US$ 20.24
